Millennium Management
JSPR icon

Millennium Management’s Jasper Therapeutics JSPR Stock Holding History

Millennium Management’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.42M Buy
1,617,531
+543,748
+51% +$755K ﹤0.01% 4141
2025
Q4 		$1.97M Buy
1,073,783
+708,844
+194% +$1.42M ﹤0.01% 3970
2025
Q3 		$869K Buy
364,939
+219,720
+151% +$666K ﹤0.01% 4722
2025
Q2 		$806K Buy
145,219
+119,280
+460% +$587K ﹤0.01% 4571
2025
Q1 		$112K Buy
+25,939
New +$173K ﹤0.01% 5420
2024
Q3 		– Sell
-22,990
Closed -$522K – 6295
2024
Q2 		$522K Sell
22,990
-88,376
-79% -$2.12M ﹤0.01% 4557
2024
Q1 		$3.27M Buy
111,366
+98,378
+757% +$1.75M ﹤0.01% 3289
2023
Q4 		$102K Buy
12,988
+6,757
+108% +$45.4K ﹤0.01% 5345
2023
Q3 		$43.6K Buy
6,231
+4,388
+238% +$53.5K ﹤0.01% 5507
2023
Q2 		$25.2K Sell
1,843
-3,629
-66% -$53.9K ﹤0.01% 5599
2023
Q1 		$99K Buy
5,472
+2,505
+84% +$46.3K ﹤0.01% 5430
2022
Q4 		$14K Buy
+2,967
New +$19.9K ﹤0.01% 6126
2022
Q1 		– Sell
-1,992
Closed -$156K – 7191
2021
Q4 		$156K Buy
+1,992
New +$186K ﹤0.01% 6059
2021
Q3 		– Sell
-9,144
Closed -$909K – 7027
2021
Q2 		$909K Buy
9,144
+7,051
+337% +$701K ﹤0.01% 4751
2021
Q1 		$207K Buy
+2,093
New +$213K ﹤0.01% 5477

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Millennium Management's JSPR Position: Q1 2026 in Review

Millennium Management increased its Jasper Therapeutics (JSPR) stake by 51% in Q1 2026, buying an estimated $755K and bringing the position to 1,617,531 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #4141.

Millennium Management first reported a position in JSPR in Q1 2021 and has held it in 15 quarters since. The position peaked at $3.27M in Q1 2024. 58 funds tracked by Wall St. Rank hold JSPR as of Q1 2026.

  • Millennium Management held 1,617,531 shares of Jasper Therapeutics worth $1.42M as of Q1 2026.
  • Millennium Management bought 543,748 Jasper Therapeutics shares in Q1 2026, an estimated $755K.
  • Jasper Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4141 holding.
  • Millennium Management first reported a position in Jasper Therapeutics in Q1 2021 and has held it in 15 quarters since.
  • Millennium Management's Jasper Therapeutics position peaked at $3.27M in Q1 2024.
  • 58 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.